Publication | Open Access
Splenectomy following JAK1/JAK2 inhibitor therapy in patients with myelofibrosis undergoing allogeneic stem cell transplantation
13
Citations
21
References
2019
Year
Splenectomy before alloHSCT might be a promising option in patients who failed to achieve significant spleen response after ruxolitinib therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1